Neumora Therapeutics

formerly NeumoraIPO

Redefining neuroscience drug development.

Public · Watertown, United States · Founded 2021 · $612.0M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$612.0M
Last Round
$112.0M Series BOct 2022
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company founded in 2021 to confront the global brain disease crisis through precision medicine. The company develops novel therapies targeting unproven mechanisms of action for neuropsychiatric and neurodegenerative disorders, pairing each drug candidate with a biomarker strategy to identify the right patients. Its pipeline includes treatments for depression, Alzheimer's agitation, and other CNS diseases.

Summary

Neumora Therapeutics is a Biotech company based in Watertown, United States, founded in 2021. It has raised $612.0M in total across 2 rounds, most recently a $112.0M Series B round in Oct 2022. Investors include ARCH Venture Partners, Altitude Life Science Ventures and Amgen.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOSep 2023
$250.1M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neumora Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/neumora-therapeutics"><img src="https://indexed.vc/api/badge/company/neumora-therapeutics" alt="Neumora Therapeutics on Indexed.vc" width="260" height="76" /></a>